SAMANTHA FOX: Open Payments
NPI 1023673407 · BRISTOL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$143,905 in 367 payments from 13 companies in 2025. Trend: 2023 $1,100 · 2024 $61,679 · 2025 $143,905
Honoraria: $89,625Travel & lodging: $25,424Speaker / faculty: $21,000Food & beverage: $5,357Consulting: $2,500
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 223 | $114,290 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 62 | $26,065 |
| ABBVIE INC. | 36 | $2,342 |
| Alkermes, Inc. | 10 | $233 |
| Supernus Pharmaceuticals, Inc. | 9 | $195 |
| E.R. Squibb & Sons, L.L.C. | 6 | $190 |
| Vanda Pharmaceuticals Inc. | 7 | $181 |
| Neuronetics, Inc. | 1 | $121 |
| Neurocrine BioSciences, Inc. | 4 | $100 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
Products named: Auvelity, CAPLYTA, VRAYLAR, Qelbree, COBENFY, LYBALVI, FANAPT, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across VA — which companies pay providers there.
